name: BC299_F20
characteristics.text: 2025-05-01
characteristics.characteristic: ENA first public
characteristics.text: ERC000011
characteristics.characteristic: ENA-CHECKLIST
characteristics.text: Institute of Microbiology, ETH Zurich
characteristics.characteristic: INSDC center name
characteristics.text: public
characteristics.characteristic: INSDC status
characteristics.text: ERS24001393
characteristics.characteristic: SRA accession
characteristics.text: BC299_F20
characteristics.characteristic: Submitter Id
characteristics.text: 2024-12-20
characteristics.characteristic: collection date
characteristics.text: SPF Faeces from Ceftriaxone treated mouse
characteristics.characteristic: description
characteristics.text: Switzerland
characteristics.characteristic: geographic location (country and/or sea)
characteristics.text: mouse gut metagenome
characteristics.characteristic: organism
characteristics.text: mouse gut metagenome
characteristics.characteristic: scientific_name
characteristics.text: Ceftriaxone treated Salmonella WT infected co-caged 20 day SPF Faeces 16S
characteristics.characteristic: title